Abstract
Background
Ulcerative colitis (UC) is primarily medically managed. Colectomy is required in patients with refractory disease or severe complications. Older studies have reported 20-year colectomy rates of over 50%, but recent studies showed decreased rates to 15%. Temporal trends in the use of colectomy in UC over the past decade (when the use of biologics has become widespread) are lacking.
Methods
Case-control study using the National Inpatient Sample database for years of 2007, 2010, 2013, and 2016 was performed. The primary outcome was determining the temporal trends in the use of colectomy in hospitalized patients with UC. Secondary outcomes were determining the total number of admissions for patients with UC and associated trend in inflation-adjusted hospital costs, charge, and length of hospital stay (LOS). Multivariate regression analyses were used to adjust for other co-variables.
Results
443,043 patients with UC were identified, of which 19,208 underwent colectomy in the study period. The mean patient age was 52 years, and 47% were female. Five percent of hospitalized patients with UC underwent colectomy in 2007, while 2.7% of patients with UC had colectomy in 2016, representing a 46% decrease in colectomies in hospitalized patients in the study period. Patients with UC displayed adjusted odds of colectomy of 0.51 (p < 0.01), adjusted additional mean hospital costs decrease by − $2898 (p < 0.01), hospital charges increase by $26,554 (p < 0.01), LOS decrease by − 2.2 days (p < 0.01) in 2016 compared to 2007.
Conclusion
The odds of colectomy in UC patients decreased significantly over the past decade, likely secondary to improved medical care.
Similar content being viewed by others
References
Ng, S.C., et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018. 390(10114): p. 2769–2778.
Baumgart, D.C. and S.R. Carding, Inflammatory bowel disease: cause and immunobiology. Lancet, 2007. 369(9573): p. 1627–40.
Loftus, C.G., et al., Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflammatory bowel diseases, 2007. 13(3): p. 254–61.
Langholz, E., et al., Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology, 1994. 107(1): p. 3–11.
Jani, N. and M.D. Regueiro, Medical therapy for ulcerative colitis. Gastroenterology clinics of North America, 2002. 31(1): p. 147–66.
Cima, R.R. and J.H. Pemberton, Medical and Surgical Management of Chronic Ulcerative Colitis. JAMA Surgery, 2005. 140(3): p. 300–310.
Leijonmarck, C.E., P.G. Persson, and G. Hellers, Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut, 1990. 31(3): p. 329–33.
Farmer, R.G., K.A. Easley, and G.B. Rankin, Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Digestive diseases and sciences, 1993. 38(6): p. 1137–46.
Ko, C.W., et al., AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology, 2019. 156(3): p. 748–764.
Øresland, T., et al., European evidence based consensus on surgery for ulcerative colitis. Journal of Crohn's and Colitis, 2014. 9(1): p. 4–25.
Thorne, K., et al., Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review. European journal of gastroenterology & hepatology, 2016. 28(4): p. 369–82.
Parragi, L., et al., Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study. Journal of Crohn's & colitis, 2018. 12(7): p. 811–818.
Murthy, S.K., et al., High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study. PloS one, 2017. 12(5): p. e0177211.
Khera, R. and H.M. Krumholz, With Great Power Comes Great Responsibility: Big Data Research From the National Inpatient Sample. Circulation. Cardiovascular quality and outcomes, 2017. 10(7): p. e003846.
Deyo, R.A., D.C. Cherkin, and M.A. Ciol, Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol, 1992. 45(6): p. 613–9.
Bewtra, M., C. Su, and J.D. Lewis, Trends in Hospitalization Rates for Inflammatory Bowel Disease in the United States. Clinical Gastroenterology and Hepatology, 2007. 5(5): p. 597–601.e1.
Smyth, C.M., et al., Increasing rates and changing patterns of hospital admissions for patients with inflammatory bowel disease in Ireland: 1996–2001. Irish Journal of Medical Science, 2005. 174(4): p. 28.
Rawla, P. and T. Sunkara, Trends of Hospitalization in Ulcerative Colitis in Patients in the United States from 2000-2014. Conference poster presented at Advances in Inflammotory Bowel Diseases 2018, Orlando, Florida.
Dias, C.C., et al., Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019. 51(7): p. 952–960.
Askling, J., et al., Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Annals of the rheumatic diseases, 2007. 66(10): p. 1339–44.
Kaplan, G.G., et al., Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. The American journal of gastroenterology, 2012. 107(12): p. 1879–87.
Xu, F., et al., Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States. Applied health economics and health policy, 2019. 17(1): p. 77–91.
Klabunde, C.N., J.L. Warren, and J.M. Legler, Assessing comorbidity using claims data: an overview. Med Care, 2002. 40(8 Suppl): p. Iv-26-35.
Author information
Authors and Affiliations
Contributions
Hassan Ghoz drafted the manuscript. Alex Kesler, Sanne A. Hoogenboom, Filippo Gavi, Bhaumik Brahmbhatt, and John Cangemi have assisted in formulating the methodology and reviewing the manuscript; Paul T. Kröner generated the project’s core hypothesis, gathered and analyzed the data, supervised, and reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This research was presented as an SSAT Plenary Session at DDW 2019 in San Diego, CA.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Ghoz, H., Kesler, A., Hoogenboom, S.A. et al. Decreasing Colectomy Rates in Ulcerative Colitis in the Past Decade: Improved Disease Control?. J Gastrointest Surg 24, 270–277 (2020). https://doi.org/10.1007/s11605-019-04474-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-019-04474-9